US Stock MarketDetailed Quotes
FBLG FibroBiologics
- 10.950
- -0.050-0.45%
Trading May 22 12:11 ET
358.27MMarket Cap-15892P/E (TTM)
11.020High10.670Low13.21KVolume10.840Open11.000Pre Close144.05KTurnover0.06%Turnover RatioLossP/E (Static)32.72MShares55.00052wk High-92.80P/B248.67MFloat Cap6.53052wk Low--Dividend TTM22.71MShs Float55.000Historical High--Div YieldTTM3.18%Amplitude6.530Historical Low10.906Avg Price1Lot Size
About FibroBiologics Company
FibroBiologics, Inc. engages in the development and commercialization of cell therapies. It focuses on treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The firm’s product pipeline includes CybroCell, CYMS101, CYWC628, TCB190, and CYTER915. The company was founded by Peter O’Heeron on April 8, 2021 and is headquartered in Houston, TX.
Company Profile
SymbolFBLG
Company NameFibroBiologics
Listing DateJan 31, 2024
Founded2021
CEOMr. Peter O’Heeron
MarketNASDAQ
Employees10
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address455 East Medical Center Boulevard,Suite 300
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77598
Phone1-281-671-5150
Company Executives
- Name
- Position
- Salary
- Peter O’Heeron
- Chairperson of Board and Chief Executive Officer
- 4.29M
- Mark Andersen, C.F.A.,C.P.A.
- Chief Financial Officer and Principal Accounting Officer
- 1.28M
- Dr. Hamid Khoja, PhD
- Chief Scientific Officer
- 1.24M
- Richard C. Cilento, Jr,M.B.A.
- Independent Director
- 376.54K
- Matthew Link
- Independent Director
- 379.54K
- Dr. Victoria Niklas, M.D.
- Independent Director
- 381.54K
- Stacy Ann Coen, M.B.A.
- Independent Director
- 384.54K
- Robert E. Hoffman, C.P.A.
- Independent Director
- 388.54K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
